Clinical trial

Safety, Tolerability, Distribution & Dose Effect of Neoadjuvant Transarterial Chemoembolization With Doxorubicin in Prostate Cancer Patients Before Radical Prostatectomy

NCT04423913

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2022-05-04

PhasePHASE2

Study timeline

Study start (actual)2022-05-04Date precision: day

Registry last updated2023-03-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

Administration of embolization beadsOTHER

Sponsors & collaborators

Centre Hospitalier Universitaire de Nīmeslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04423913 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.